ASX:FREPharmaceuticals
Firebrick Pharma First Half 2025 Earnings: AU$0.007 loss per share (vs AU$0.005 loss in 1H 2024)
Firebrick Pharma ( ASX:FRE ) First Half 2025 Results Key Financial Results Revenue: AU$197.1k (down 89% from 1H 2024...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.